Get the Stockscreener App
4.49
4.91%
0.21
After Hours:
4.56
0.07
+1.56%
Myomo Inc stock is traded at $4.49, with a volume of 246.83K.
It is up +4.91% in the last 24 hours and down -16.54% over the past month.
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
See More
Previous Close:
$4.28
Open:
$4.32
24h Volume:
246.83K
Relative Volume:
0.60
Market Cap:
$154.03M
Revenue:
$25.24M
Net Income/Loss:
$-8.38M
P/E Ratio:
-19.52
EPS:
-0.23
Net Cash Flow:
$-9.54M
1W Performance:
+0.22%
1M Performance:
-16.54%
6M Performance:
+20.38%
1Y Performance:
+30.52%
1-Day Range:
$4.293
$4.51
1-Week Range:
$4.185
$4.51
52-Week Range:
$2.76
$7.1699
Myomo Inc Stock (MYO) Company Profile
Name
Myomo Inc
Sector
Industry
Phone
617-996-9058
Address
One Broadway, 14th Floor, Cambridge, MA
Compare MYO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
4.49 | 154.03M | 25.24M | -8.38M | -9.54M | -0.23 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-24 | Initiated | Craig Hallum | Buy |
| May-20-24 | Initiated | Lake Street | Buy |
| Dec-15-23 | Initiated | H.C. Wainwright | Buy |
| Nov-11-20 | Upgrade | ROTH Capital | Neutral → Buy |
| May-27-20 | Initiated | Dougherty & Company | Buy |
| Oct-02-17 | Initiated | H.C. Wainwright | Buy |
View All
Myomo Inc Stock (MYO) Latest News
Myomo Announces Upcoming Changes to its Board of Directors | MYO Stock News - GuruFocus
Myomo at Needham Conference: Strategic Growth and Market Expansion - Investing.com Australia
Myomo at Needham Conference: Strategic Growth and Market Expansion By Investing.com - Investing.com India
Myomo board members to depart at June annual meeting By Investing.com - Investing.com South Africa
Myomo Announces Upcoming Changes To Board - citybiz
Myomo board members to depart at June annual meeting - Investing.com Australia
Myomo Announces Board Transition with Director Departures - TipRanks
Myomo Announces Upcoming Changes to its Board of Directors - Bluefield Daily Telegraph
Myomo Reshapes Board Leadership Following Medicare Coverage Victory - Stock Titan
Myomo: Balancing CMS Tailwinds With Long-Term Risks (NYSE:MYO) - Seeking Alpha
(MYO) On The My Stocks Page - news.stocktradersdaily.com
Short Interest in Myomo, Inc. (NYSEAMERICAN:MYO) Expands By 22.3% - Defense World
Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference - The Joplin Globe
Medical Robotics Pioneer Myomo Reveals Growth Strategy at Major Healthcare Conference - Stock Titan
How the (MYO) price action is used to our Advantage - news.stocktradersdaily.com
Myomo (NYSEAMERICAN:MYO) Given New $11.00 Price Target at Ascendiant Capital Markets - Defense World
Long Term Trading Analysis for (MYO) - Stock Traders Daily
HC Wainwright Issues Optimistic Forecast for Myomo Earnings - Defense World
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates - MSN
What is HC Wainwright’s Forecast for Myomo FY2026 Earnings? - Defense World
Myomo director Kirk Thomas buys $37,000 in common stock By Investing.com - Investing.com South Africa
Top Executive Sells Thousands of Myomo Shares! - TipRanks
Myomo director Kirk Thomas buys $37,000 in common stock - Investing.com India
Myomo’s chief commercial officer sells $247,564 in stock By Investing.com - Investing.com South Africa
Myomo’s chief commercial officer sells $247,564 in stock - Investing.com India
HC Wainwright Forecasts Strong Price Appreciation for Myomo (NYSEAMERICAN:MYO) Stock - Defense World
Myomo chief medical officer sells $165,018 in stock By Investing.com - Investing.com Canada
Myomo chief medical officer sells $165,018 in stock - Investing.com India
Myomo stock price target raised to $9.50 by H.C. Wainwright - Investing.com India
Myomo’s Strong Financial Performance and Promising Growth Prospects Drive Buy Rating - TipRanks
Myomo price target raised to $9.50 from $7.50 at H.C. Wainwright - TipRanks
Craig Hallum Issues Positive Forecast for Myomo (NYSEAMERICAN:MYO) Stock Price - Defense World
Myomo Inc. Reports Record Growth Amid Challenges - TipRanks
Myomo price target raised to $11 from $9 at Craig-Hallum - TipRanks
Myomo, Inc. (AMEX:MYO) Q4 2024 Earnings Call Transcript - Insider Monkey
Myomo’s revenue jumps 154% to USD 12.1M in Q4 2024 - Medical Buyer
Myomo Inc (MYO) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Market ... - Yahoo
Myomo Reports Record Revenue and Positive Cash Flow - TipRanks
Earnings call transcript: Myomo Q4 2024 beats forecasts, shares surge By Investing.com - Investing.com Australia
Myomo earnings beat by $0.01, revenue topped estimates - Investing.com India
Earnings call transcript: Myomo Q4 2024 beats forecasts, shares surge - Investing.com India
Myomo Inc Stock (MYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):